A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Evolus, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 196,200 shares of EOLS stock, worth $2.13 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
196,200
Holding current value
$2.13 Million
% of portfolio
0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$9.99 - $14.91 $1.96 Million - $2.93 Million
196,200 New
196,200 $2.75 Million
Q1 2023

May 15, 2023

BUY
$7.81 - $11.05 $17,111 - $24,210
2,191 New
2,191 $18,000
Q2 2022

Aug 15, 2022

SELL
$10.22 - $13.94 $3.17 Million - $4.32 Million
-309,800 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$5.22 - $11.78 $4,176 - $9,424
-800 Reduced 0.26%
309,800 $3.48 Million
Q4 2021

Feb 14, 2022

BUY
$5.37 - $8.38 $1.67 Million - $2.6 Million
310,600 New
310,600 $2.02 Million
Q2 2021

Aug 16, 2021

SELL
$8.42 - $13.96 $670,232 - $1.11 Million
-79,600 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$3.2 - $16.51 $254,720 - $1.31 Million
79,600 New
79,600 $1.03 Million
Q1 2020

May 15, 2020

SELL
$3.53 - $12.21 $731,416 - $2.53 Million
-207,200 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$11.58 - $17.37 $2.4 Million - $3.6 Million
207,200 New
207,200 $2.52 Million
Q3 2019

Nov 15, 2019

SELL
$13.91 - $19.87 $3.96 Million - $5.66 Million
-285,000 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$13.19 - $28.36 $3.76 Million - $8.08 Million
285,000 New
285,000 $4.17 Million
Q1 2019

May 15, 2019

SELL
$12.43 - $28.91 $4.85 Million - $11.3 Million
-389,985 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$10.57 - $19.29 $3.89 Million - $7.1 Million
-367,972 Reduced 48.55%
389,985 $4.64 Million
Q3 2018

Nov 14, 2018

BUY
$17.31 - $29.82 $13.1 Million - $22.6 Million
757,957 New
757,957 $14.1 Million

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $609M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.